Group 1 - The company reported a total operating revenue of 155 million yuan, an increase of 2.41 million yuan compared to the same period last year, marking three consecutive years of growth, with a year-on-year increase of 1.58% [1] - The net profit attributable to shareholders was -7.22 million yuan, and the net cash inflow from operating activities was -6.03 million yuan, an increase of 11.82 million yuan compared to the same period last year [1] Group 2 - The company's latest debt-to-asset ratio is 18.85%, ranking 7th among disclosed peers [3] - The latest gross profit margin is 63.21%, ranking 15th among disclosed peers, with an increase of 1.05 percentage points from the previous quarter and an increase of 3.65 percentage points from the same period last year [3] - The latest return on equity (ROE) is -0.96% [3] - The diluted earnings per share is -0.05 yuan [3] Group 3 - The company's total asset turnover ratio is 0.17 times, and the inventory turnover ratio is 0.61 times [4] - The number of shareholders is 12,300, with the top ten shareholders holding 112 million shares, accounting for 70.03% of the total share capital [4] - The largest shareholder is Guangdong Jino Health Technology Co., Ltd., holding 45.00% of the shares [4]
粤万年青(301111.SZ):2025年中报营业总收入为1.55亿元,实现3年连续上涨